|
ÆÊÄ¿³ØÆà |
[±¹³» CRO] MWÆÀÀå
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
5³â¡è |
05.31 |
04.02 |
|
|
¿¢½º´ÙÀÓ(ÁÖ) |
Post-Marketing Surveillance (´ë¸®~°úÀå) - ±¹³» À¯¸í Á¦¾à
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
PL/PV/PMS/MD |
5³â¡è |
ä¿ë½Ã |
06.01 |
|
|
ÆÄÀε崺·ÎµåÄÁ¼³Æà |
Patient Safety Lead (Â÷ºÎÀå±Þ) / ¿Ü±¹°è Á¦¾à»ç
¼¿ï ÀüÁö¿ª, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
6³â¡è |
ä¿ë½Ã |
05.03 |
|
|
(ÁÖ)ÇÇÇÃÄɾî½áÄ¡ |
Pharmacist -¿Ü±¹°èÁ¦¾à»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
6³â¡è |
ä¿ë½Ã |
07.13 |
|
|
ÆÊÄ¿³ØÆà |
[±¹³»Á¦¾à»ç] Medical Writer
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
7³â¡è |
05.31 |
04.17 |
|
|
ÆÊÄ¿³ØÆà |
[±¹³» CRO] MD(Medical Doctor)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
7³â¡è |
06.30 |
05.14 |
|
|
ÆÊÄ¿³ØÆà |
[±Û·Î¹ú Á¦¾à»ç] Medical Affairs Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
8³â¡è |
05.31 |
04.24 |
|
|
ÆÊÄ¿³ØÆà |
[±Û·Î¹ú Á¦¾à»ç] Medical Manager
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
8³â¡è |
05.31 |
04.26 |
|
|
ÆÊÄ¿³ØÆà |
[±Û·Î¹ú Á¦¾à»ç] Medical Manager
¼¿ï ¼ÛÆı¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
PL/PV/PMS/MD |
8³â¡è |
06.30 |
05.10 |
|
|
ÆÊÄ¿³ØÆà |
[±Û·Î¹ú Á¦¾à»ç] Medical Manager
¼¿ï ¼ÛÆı¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
PL/PV/PMS/MD |
8³â¡è |
05.31 |
04.24 |
|
|
JN Partners |
[À¯¸í±¹³»Á¦¾à»ç] PVÆÀÀå
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
9³â¡è |
ä¿ë½Ã |
11.09 |
|
|
JN Partners |
[±¹³»¹× ¿Ü±¹°è Á¦¾à»ç] PV ¸Å´ÏÀú
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
9³â¡è |
ä¿ë½Ã |
01.24 |
|
|
JN Partners |
[À¯¸í±¹³»Á¦¾à»ç] PVÆÀÀå
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
9³â¡è |
ä¿ë½Ã |
12.07 |
|
|
JN Partners |
[À¯¸í±¹³»Á¦¾à»ç] PVÆÀÀå
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
9³â¡è |
ä¿ë½Ã |
11.12 |
|
|
JN Partners |
[À¯¸í±¹³»Á¦¾à»ç] PVÆÀÀå
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
9³â¡è |
ä¿ë½Ã |
11.16 |
|